Get the Stockscreener App
13.64
1.87%
-0.26
After Hours:
13.69
0.05
+0.37%
Dynavax Technologies Corp stock is traded at $13.64, with a volume of 2.86M.
It is down -1.87% in the last 24 hours and up +4.20% over the past month.
See More
Previous Close:
$13.90
Open:
$13.9
24h Volume:
2.86M
Relative Volume:
1.48
Market Cap:
$1.63B
Revenue:
$260.81M
Net Income/Loss:
$20.48M
P/E Ratio:
104.92
EPS:
0.13
Net Cash Flow:
$22.67M
1W Performance:
-0.73%
1M Performance:
+4.20%
6M Performance:
+18.61%
1Y Performance:
+13.48%
1-Day Range:
$13.59
$13.99
1-Week Range:
$13.46
$14.01
52-Week Range:
$9.74
$14.63
Dynavax Technologies Corp Stock (DVAX) Company Profile
Name
Dynavax Technologies Corp
Sector
Phone
(510) 848-5100
Address
2100 POWELL STREET, EMERYVILLE, CA
Compare DVAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
13.64 | 1.63B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
163.75 | 73.33B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.13 | 47.80B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.37 | 46.89B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.29 | 18.67B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.53 | 13.99B | 612.78M | -86.37M | -62.91M | -0.87 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | Goldman | Neutral → Sell |
| Feb-01-24 | Initiated | Goldman | Neutral |
| Sep-27-22 | Initiated | JMP Securities | Mkt Outperform |
| Jan-06-22 | Resumed | Goldman | Buy |
| Aug-06-21 | Initiated | Goldman | Buy |
| Aug-07-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-03-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-15-20 | Initiated | Evercore ISI | Outperform |
| Oct-18-19 | Initiated | H.C. Wainwright | Buy |
| Jul-11-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-27-19 | Reiterated | Cantor Fitzgerald | Overweight |
| May-10-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-08-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Feb-14-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-25-17 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-15-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-31-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-31-17 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Apr-28-16 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-27-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Initiated | RBC Capital Mkts | Outperform |
| Nov-25-13 | Upgrade | MLV & Co | Hold → Buy |
| Feb-25-13 | Downgrade | MLV & Co | Buy → Hold |
| Nov-16-12 | Reiterated | MLV & Co | Buy |
View All
Dynavax Technologies Corp Stock (DVAX) Latest News
Wall Street Analysts See an 83.1% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High? - Yahoo Finance
Dynavax at Barclays Healthcare: Strategic Growth and Market Expansion - Investing.com
Dynavax technologies’ president & COO David Novack sells $471,473 in stock - Investing.com Canada
Dynavax Activist Investor Deep Track Capital Sends Letter to Company Board, Urging Director, Strategy Changes - Marketscreener.com
Deep Track Capital pushes for board changes at Dynavax By Investing.com - Investing.com Canada
Dynavax Turns Heads As HEPLISAV-B Shows Steady Growth In The Expanding Hepatitis B Vaccine Market - RTTNews
Deep Track Capital pushes for board changes at Dynavax - Investing.com
Major Dynavax Investor Pushes for Board Changes, Questions $265M Debt - StockTitan
Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors - Yahoo Finance
Dynavax Technologies Corp. to Host Earnings Call - ACCESS Newswire
Dynavax at TD Cowen Conference: Strategic Growth and Future Plans - Investing.com
Dynavax Signs Debt Refinancing Deals, Plans $8 Million Stock Buyback -March 06, 2025 at 07:54 am EST - Marketscreener.com
Dynavax Announces Convertible Debt Refinancing -March 06, 2025 at 07:28 am EST - Marketscreener.com
Dynavax Announces Convertible Debt Refinancing, Common Stock Share Repurchase - Nasdaq
Dynavax stock hits 52-week high at $14.05 amid robust growth - Investing.com Canada
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Is Dynavax Technologies Corporation (DVAX) the Best Small Cap Pharma Stock to Buy Now? - Insider Monkey
Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Dynavax's SWOT analysis: hepatitis B vaccine maker's stock poised for growth - Investing.com
Dynavax Technologies (NASDAQ:DVAX) Upgraded to Buy at StockNews.com - Defense World
Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 81.92%: Read This Before Placing a Bet - Yahoo Finance
HC Wainwright Has Optimistic Outlook of DVAX FY2026 Earnings - Defense World
New York State Teachers Retirement System Decreases Holdings in Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Dynavax Technologies (NASDAQ:DVAX) Hits New 12-Month High – Should You Buy? - Defense World
Dynavax Technologies (NASDAQ:DVAX) Earns Buy Rating from HC Wainwright - Defense World
Dynavax Technologies Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Deep Dive Into Dynavax Technologies Stock: Analyst Perspectives (4 Ratings) - Benzinga
DVAX stock touches 52-week high at $13.9 amid robust performance By Investing.com - Investing.com South Africa
DVAX stock touches 52-week high at $13.9 amid robust performance - Investing.com
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2024 Earnings Call Transcript - Insider Monkey
H.C. Wainwright maintains Buy on Dynavax stock with $31 target - Investing.com
JMP raises Dynavax stock target to $33, maintains rating - Investing.com
Dynavax Technologies: Q4 Earnings Snapshot - CTPost
Dynavax Technologies Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Dynavax Technologies Corp (DVAX) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada
Dynavax Technologies Corporation Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com
Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript - AOL
Dynavax Technologies (DVAX) Surpasses Q4 Earnings and Revenue Estimates - MSN
Earnings call transcript: Dynavax Q4 2024 shows EPS beat, revenue miss - Investing.com
High Growth Tech Stocks To Watch In February 2025 - Yahoo Finance
Dynavax Technologies climbs as investor begins proxy fight (update) - MSN
Dynavax under fire as investor targets vaccine maker’s board - The Business Journals
Dynavax Technologies (DVAX) Projected to Post Earnings on Thursday - Defense World
Palumbo Wealth Management LLC Invests $275,000 in Dynavax Technologies Co. (NASDAQ:DVAX) - MarketBeat
Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors By Reuters - Investing.com
Dynavax Technologies Reiterates Board Change Already Underway -February 19, 2025 at 05:53 pm EST - Marketscreener.com
Dynavax defends strategy amid board nomination dispute - Investing.com
Deep Track Capital Nominates Four Candidates For Election To Dynavax Technologies' Board At 2025 Annual Meeting - Marketscreener.com
Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors -February 19, 2025 at 08:00 am EST - Marketscreener.com
Life Sciences Investor Deep Track Launches Proxy Fight… -February 19, 2025 at 08:00 am EST - Marketscreener.com
Exclusive-Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors - Marketscreener.com
Dynavax Technologies Corp Stock (DVAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):